Related Experiment Video
Updated: Jun 6, 2026

Combining Reflectance Confocal Microscopy with Optical Coherence Tomography for Noninvasive Diagnosis of Skin Cancers via Image Acquisition
Published on: August 18, 2022
Facial basal cell carcinoma in a young patient with Crohn disease
John V Williams1, Peter J Revington
1Department of Oral & Maxillofacial Surgery, Frenchay Hospital, Bristol, UK. j.v.williams@doctors.org.uk
Abstract:
A 26-year-old man with Crohn disease developed a 10-mm-diameter facial basal cell carcinoma. He was referred to our department, and the tumor was excised with a clear margin. The wound was closed by primary closure, and he made an uneventful postoperative recovery with a satisfactory cosmetic result. Although the increased risk of nonmelanoma skin cancer in immunosuppressed solid organ transplant patients is well known, the association with inflammatory bowel disease remains unclear. There are few articles in the literature on this topic, and the authors believe this to be the first documented case of facial basal cell carcinoma occurring in the context of Crohn disease. Of particular interest is the very young age at presentation.
Related Concept Videos
Inflammatory Bowel Disease III: Crohn's Disease
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

